Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation
Open Access
- 13 July 2020
- journal article
- research article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 51 (7) , 511-519
Abstract
Background: Arteriovenous (AV) fistulas are considered the gold standard for ensuring safe and long-term vascular access in patients with haemodialysis-dependent end-stage renal disease. However, previous studies demonstrated that high-flow AV fistulas might add additional cardiovascular burden in the post-transplant setting, leading to frequent fistula closure in this population. Currently, there is no consensus regarding management of high-flow fistulas in post-transplant patients with stable kidney function. The present randomized controlled trial examines the effect of prophylactic AV fistula closure on high-output heart failure. Methods: Twenty-eight kidney transplant patients with stable graft function, absence of pre-existing severe cardiac failure, and brachial arterial flow rate of at least 1,500 mL/min were recruited and randomized in a 1:1 ratio to an intervention and control group, respectively. The intervention group was subject to immediate fistula ligature. Patients within the control group were referred to fistula ligature only if the main study endpoint high-output heart failure was reached. The latter was defined by the presence of at least 1 clinical sign (i.e., worsening NYHA score) and at least 2 of the following echocardiographic parameters: diameter of right atrium (major) >53 mm, right atrium (minor) >44 mm, inferior vena cava ≥21 mm, right pulmonary artery >20 mm, TAPSE 40 mm Hg, and/or left ventricular eccentricity index Results: High-output heart failure attributable to high-flow fistula was reported in 5 of 13 control patients (38.5%), whereas no patient in the intervention group presented with clinical and echocardiographic signs of high-output heart failure during the follow-up period. Thus, prophylactic ligature of high-flow fistulas avoided high-output heart failure in our patient population (p = 0.013). Three patients in the control group, however, had to undergo fistula ligature due to aneurysm formation (n = 2) and steal phenomenon (n = 1). Median NT-proBNP levels decreased from 317 ng/L pre-ligature to 223 ng/L post-ligature (p = 0.003). Serum creatinine levels did not significantly differ before and after AV fistula ligature (1.69 vs. 1.60 mg/dL, respectively, p = 0.059). Improvement of echocardiographic findings (e.g., a decrease in systolic pulmonary arterial pressure) was found in 7 of 8 ligature patients but did not reach statistical significance. Conclusion: Prophylactic ligature of high-flow AV fistulas after kidney transplantation can avoid high-output heart failure, and a more liberal approach to close AV fistulas might be justified.Keywords
This publication has 29 references indexed in Scilit:
- Practice patterns in arteriovenous fistula ligation among kidney transplant recipients in the United States Renal Data SystemsJournal of Vascular Surgery, 2019
- The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis PatientsInternal Medicine, 2017
- The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function declineNephrology Dialysis Transplantation, 2016
- Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertensionCardiovascular Ultrasound, 2013
- Reversible pulmonary hypertension in a kidney transplant with patent A-V fistulaClinical Kidney Journal, 2012
- Impact of dialysis access fistula on cardiac function after kidney transplantation.2012
- Arteriovenous Fistula ToxicityBlood Purification, 2011
- Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistulaAmerican Journal of Kidney Diseases, 2002
- Haemodynamics of Brachial Arteriovenous Fistula DevelopmentThe Journal of Vascular Access, 2000
- Cardiac Effects of Persistent Hemodialysis Arteriovenous Access in Recipients of Renal AllograftCardiology, 1999